Bacillus subtilis RZ001 improves intestinal integrity and alleviates colitis by inhibiting the Notch signalling pathway and activating ATOH-1. Issue 2 (13th March 2020)

• Record Type: Journal Article
• Authors: Li, Yanru; Zhang, Tengxun; Guo, Congcong; Geng, Meng; Gai, Sailun; Qi, Wei; Li, Zhongyuan; Song, Yajian; Luo, Xuegang; Zhang, Tongcun; Wang, Nan
• Is Part Of: Pathogens and disease. Volume 78:Issue 2(2020)
• Publication Date: 2020-03-13
• Subjects: mucin 2 -- intestinal barrier -- ulcerative colitis -- Notch signalling pathway; Medical microbiology -- Periodicals; Pathogenic microorganisms -- Periodicals; Communicable diseases -- Microbiology -- Periodicals; Communicable diseases -- Pathogenesis -- Periodicals; Host-parasite relationships -- Periodicals; Systems biology -- Periodicals; 616.904105
• DOI: 10.1093/femspd/ftaa016
• Languages: English
• ISSNs: 2049-632X

Abstract

ABSTRACT: Intestinal mucosal barriers help the body resist many intestinal inflammatory diseases, such as inflammatory bowel disease (IBD). In this study, we identified a novel bacterium promoting the repair of intestinal mucosa and investigated the potential mechanisms underlying its activity. Culture supernatant of Bacillus subtilis RZ001 upregulated the expression of mucin 2 (MUC2) and tight junction (TJ) proteins in HT-29 cells in vitro . Oral administration of B. subtilis RZ001 may have significantly reduced symptoms such as the dextran sulfate sodium (DSS)-induced decrease in body weight, shortening of colon length and overproduction of proinflammatory factors. The number of goblet cells and levels of MUC2 and TJ proteins were significantly increased in adult mice fed with B. subtilis RZ001. B. subtilis RZ001 cells upregulated the levels of MUC2 in the intestinal organoids. Furthermore, culture supernatant of B. subtilis RZ001 could suppress the Notch signalling pathway and activate the expression of atonal homolog 1 (Atoh1). The transcription factor Atoh1 is required for intestinal secretory cell differentiation and activates transcription of MUC2 via binding to E-boxes on the MUC2 promoter. Taken together, B. subtilis strain RZ001 has the potential for treating IBD. The present study is helpful to elucidate the mechanisms of B. subtilis action. Abstract : A new probiotic strain B. subtilis RZ001 can repair the damaged intestinal tract and alleviate colitis by inhibiting the Notch signalling pathway and the depletion of goblet cells.